These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26582395)
1. Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization. Kim JH; Moon SH; No M; Kim JJ; Choi EJ; Cho BJ; Kim JS; Kim IH; Kim IA Cancer Res Treat; 2016 Jul; 48(3):1130-40. PubMed ID: 26582395 [TBL] [Abstract][Full Text] [Related]
2. Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice. Tsai CL; Liu WL; Hsu FM; Yang PS; Yen RF; Tzen KY; Cheng AL; Chen PJ; Cheng JC Hepatology; 2018 Feb; 67(2):586-599. PubMed ID: 28646552 [TBL] [Abstract][Full Text] [Related]
3. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6. Kim IA; No M; Lee JM; Shin JH; Oh JS; Choi EJ; Kim IH; Atadja P; Bernhard EJ Radiother Oncol; 2009 Jul; 92(1):125-32. PubMed ID: 19329208 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection. Chen YT; Zang XF; Pan J; Zhu XL; Chen F; Chen ZB; Xu Y Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):751-8. PubMed ID: 22651689 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis. Chung YL; Lee MY; Pui NN Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590 [TBL] [Abstract][Full Text] [Related]
10. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs. Wang Y; Wallach J; Duane S; Wang Y; Wu J; Wang J; Adejare A; Ma H Drug Des Devel Ther; 2017; 11():1369-1382. PubMed ID: 28496307 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy of cancer with histone deacetylase inhibitors. Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724 [TBL] [Abstract][Full Text] [Related]
13. The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiotherapy. Hehlgans S; Storch K; Lange I; Cordes N Radiother Oncol; 2013 Oct; 109(1):126-32. PubMed ID: 24060178 [TBL] [Abstract][Full Text] [Related]
14. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays. Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma. Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492 [TBL] [Abstract][Full Text] [Related]
17. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells. Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylation as a target for radiosensitization. Cerna D; Camphausen K; Tofilon PJ Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459 [TBL] [Abstract][Full Text] [Related]